| | ACE Inhibitors Slow Progression of Chronic Renal Disease - CME Teaching Brief - MedPage Today |
 | | Explain that ACE inhibitor treatment requires close monitoring of serum potassium, use of diuretics, and dietary potassium restriction and sodium restriction. |
 | | Both ACE inhibitors and angiotensin receptor blockers (ARBs) are known to increase the risk of hyperkalemia, so many clinicians, according to Dr. Hebert, routinely stop ACE inhibitors or ARBs when patients progress to stage 4 kidney disease. |
 | | But Dr. Hebert was cautious in his interpretation of the Hou data, noting that the Chinese researchers used an ACE inhibitor dose that was half the maximal recommended dose for patients with kidney disease, which is significantly higher than the 15 to 25% of maximal dose reported by other researchers. |
| www.medpagetoday.com /Nephrology/GeneralNephrology/tb/2464 (1136 words) |